Unilabs

How can AI-driven diagnostics save lives? Join us at the Ars Electronica Festival for Art, Technology, and Society in Austria, from 4 September. As an international leader in diagnostic services, this year's theme, “HOPE – Who Will Turn the Tide,” aligns perfectly with Unilabs’ mission to power health and maximise life. We're excited to showcase the ways in which Unilabs is already harnessing AI to revolutionise healthcare; to transform early diagnosis, advance research, and personalise diagnostic services. If you're attending the festival, don't miss our special panel session on ‘STARTS’ day on 5 September. This is a day focused to how we can reclaim, reimagine and regulate our digital landscape. Unilabs’ Head of AI Centre of Excellence, Claudio Silvestrin, will explore AI's future impact and considerations in clinical practice, alongside prominent digital researchers:  - Albert Ortig, founder of Netural GmbH - Apolinário Passos (Poli), Head of Machine Learning for Art and Creativity at Hugging Face - Frederike Kaltheuner, Europe and Global Governance Lead at the AI Now Institute - Thomas Nayer, founder of Dogether For more details, visit: https://lnkd.in/gKmsGDyV #AI #arselectronica24 #arselectronica #Healthcare

Groundbreaking innovations in molecular profiling and targeted therapy are unlocking more precise and personalised approaches to diagnosis and treatment, transforming cancer patients’ fight against the disease.  Our latest technology innovations range from allele-specific PCR, which can detect specific single-nucleotide variants (SNVs) in a patient's DNA, to next-generation sequencing (NGS) and more traditional methods like Sanger sequencing for detecting unknown mutations in genes. These tools allow us to identify known mutations that have implications for treatment decisions, and provide valuable information about single-nucleotide changes.   Combined with targeted therapy, we are able to enhance treatment effectiveness while minimising damage to healthy cells and support a better quality of care and life for cancer patients. We interview with Unilabs’ Dr Jana Verebová on molecular testing and new cancer diagnostic tests here: https://lnkd.in/e4ftsHTY As research advances, we expect more targeted therapies and broader molecular testing, which will further transform cancer treatment and prognosis. #Cancer #Oncology #Healthcare 

AI is revolutionising medical fields like radiology by streamlining diagnostic processes, enhancing productivity, and ultimately improving patient outcomes. We spoke with Dr Stavroula Kyriazi, MD, clinical lead for the emergency radiology section at Unilabs’ AI Centre of Excellence, to explore these developments in-depth, focusing on how healthcare professionals are navigating this new frontier of AI-assisted healthcare. At Unilabs, our AI solutions are enhancing detection of over 100 different conditions, including brain aneurysms, tumours and haemorrhages, with three significant AI radiology solutions looking at CT Intracranial angiograms, covering images with and without contrast. An additional three of our innovative AI applications are frequently used in emergency brain CT scanning. Over 250,000 Unilabs examinations have been AI-assisted to date. Read about the intersection between radiology and AI as well as Dr Kyriazi’s insights in our interview here:  https://lnkd.in/eJMfWRNV #AI #Radiology #Tech #Healthcare

“What I find most enjoyable in my work is the significant variation in daily tasks. We receive a wide range of specimens, and it takes time to gain experience and encounter the different variations, so we often seek advice from colleagues, which also makes the work interesting and challenging.” – Unilabs Biomedical Analyst Katarina Huhmarniemi In the second instalment of our series spotlighting Unilabs pathology technicians from across the world, we spoke to Biomedical Analyst Katarina Huhmarniemi in Sweden about her work and the measures taken to guarantee accuracy and precision in laboratory procedures. Read more here: https://lnkd.in/e_at4rFf  #Pathology #Medicine #Diagnostics #UnilabsCareers

Understanding genetic factors in hereditary cancer helps tailor proactive management and preventive measures, aiming for the best possible patient outcomes and support. Some cancers have a stronger genetic predisposition, with hereditary syndromes making up around 3-20% of all cancer cases. Unilabs provides oncogenetic consultations which can unlock possible risk-reducing interventions and provide informed clinical decisions for the patient. Developments in next-generation sequencing allow us to quickly analyse multiple genes at once, helping identify harmful gene changes linked to hereditary cancers. Additionally, new treatments like PARP inhibitors and checkpoint inhibitors show promise for cancers with specific genetic mutations.  Learn more from Unilabs' Oncogenetics specialist Dr Zuzana Mazerikova.  https://lnkd.in/eN_vp_64 #Genetics #Oncology #Cancer #Healthcare 

Lung cancer is one of the most common and deadliest cancers globally.    Following World Lung Cancer Day, Unilabs highlights the importance of continuing to raise awareness and empowering those affected by this devastating disease. To shed light on the current landscape of lung cancer, we had the opportunity to sit down with Matthew Ginder, Unilabs’ TMC Head of Business Unit UK, who brings a wealth of knowledge and experience in this field.     Matthew gives insights into the critical aspects of lung cancer, emphasising the importance of early detection and the collective efforts needed to combat this illness. Read on to learn more about these topics, along with the groundbreaking research Unilabs is leading on early diagnosis through the UK's national lung health check programme.     #WorldLungCancerDay #Cancer #HealthCare 

In this interview with Dr Carlos Mendes, Clinical Pathology Medical Specialist at Unilabs, we explore the diverse spectrum of blood cancers, including leukaemia and myelodysplastic syndromes, and the significant role of a multi-disciplinary approach combining clinical, laboratory and genomic data to ensure a holistic care approach. He also looks at advancements in the sensitivity and specificity of lab tests which are revolutionising the field. Read the full interview in our blog here: https://lnkd.in/efzdhYN7 #Cancer #BloodCancerAwarenessMonth #HealthCare 

A major milestone for brain health diagnostics and research across Europe and beyond. We’re proud to share Unilabs has entered a multi-year partnership with C2N Diagnostics, LLC (“C2N”), a pioneer in advanced diagnostic solutions for Alzheimer’s disease and related neurological disorders. The partnership will expand reach of C2N’s Precivity™ Blood Tests in over 75 countries to transform early diagnosis and research of Alzheimer’s disease, with plans to facilitate a technology transfer of C2N’s proprietary portfolio of Alzheimer’s blood biomarkers to deliver a Unilabs testing network across Europe, including Norway and Switzerland, and the United Kingdom. The agreement will also provide access in Peru, Saudi Arabia, and the United Arab Emirates beyond existing C2N partnerships.    C2N and Unilabs expect the Precivity™ portfolio of blood tests will become available to Unilabs customers over the coming months, depending on geographic region. Tests will only be available for order by qualified healthcare providers. We are confident these tests can help in achieving better outcomes for patients, as we continue in our mission to power health and maximise life. Find out more: https://lnkd.in/gfW_4MCy #Alzheimers #Healthcare #PublicHealth #MedicalResearch  

Our commitment to improving patient care and treatment drives us to continually explore new ways to support healthcare practitioners and patients. Explore the latest news from our specialist global pathology, laboratory and imaging teams: 💯 In May the Journal of Personalised Medicine published our contribution to a meticulous analysis of lung cancer patient pathways in the Portuguese healthcare system, identifying several areas for enhancement and comprehensive proposals to address them. Read the paper: https://lnkd.in/eupdJKcT  👩⚕️ Led by Dr Mariana Costa, in March we joined one of the world’s foremost international HPV-related congresses, EUROGIN Conference Conference, to present pioneering research on the potential of DNA methylation to transform cervical cancer screening. A showcase of how our leading laboratories and cross-country partnerships can help healthcare providers unlock faster treatment and reduce healthcare costs. Learn more about our ongoing areas of HPV research here: https://lnkd.in/e_QPpiNm 🤝 We announced plans in May to expand our collaboration with Clínica Good Hope, increasing access to Unilabs sites in Peru for laboratory sample collection and imaging tests across the region. Learn about the new standards we’ve set for diagnostic accuracy and efficiency of turnaround time (TAT) through the partnership: https://lnkd.in/ewu6EaSk 👀 Distinguished Unilabs pathologist and a member of the Swiss Society of Pathology, Dr Hohl, marked Skin Cancer Awareness month with an interview outlining the advancements in diagnostic technology that are leading to considerable progress in the understanding and earlier detection of melanoma. View: https://lnkd.in/e66Fzuj4  🚀 Unilabs AI Project manager, Tomasz Stankiewicz, unpacked the transformative power of AI to augment pathologists' capabilities. AI offers significant opportunities to assist clinicians, according to Stankiewicz. Learn more about our approach to critical considerations in AI application in areas like radiology:  https://lnkd.in/gYNsSSEV Missed these updates? Be sure to follow us, and catch up across more on our website: https://lnkd.in/eSVTcyzj #HealthCare #Diagnostics #Radiology #Pathology

Non-invasive prenatal screening (NIPT) is one of the latest genetic diagnostic tools offered by Unilabs that is transforming approaches to prenatal care. Unilabs medical genetics specialist and laboratory manager, RNDr Renáta Zemjarová Mezenská, explores its applications and other critical diagnostic tests that can support individuals and families throughout their reproductive journey in our latest interview: https://lnkd.in/gzwxcJAY  #Genetics #Genomics #HealthCare #Diagnostics